Freelancer profile translated to English.

Description

Experienced professional in corporate finance, with strong expertise in the pharmaceutical industry. During my last position as Chief Financial Officer at Fidia Farmaceutici, I turned around the financial performance of the French subsidiary and led acquisition and product integration projects. With experience at Lilly, Sanofi, and UPSA, I have managed complex portfolios and led M&A projects, while optimizing financial performance. My dual academic background, as a chemical engineering graduate complemented by an HEC Paris MBA specializing in Strategy and Finance, as well as my skills in project management and financial analysis, make me a strategic and operational leader, capable of navigating international environments and delivering tangible results.

Industry field of expertise

Languages

French
Native or bilingual
English
Native or bilingual

Workplace preferences

Can work on-site

Paris (up to 50km)

fidia
Chief Financial Officer France / Head of Human Resources France
PHARMACEUTICALS INDUSTRY
December 2023 - February 2025 (1 year and 2 months)
Paris, France
• Turnaround the financial performance of the French subsidiary €8.2M turnover (+16% turnover / +3pts operating margin / -6 days DSO)
• Orchestrate a redundancy plan for six employees, ensuring a respectful and compliant transition with regulations, while maintaining the productivity and morale of the remaining team
• Structure the finance function by implementing BI tools for sales tracking by geography and optimizing closing procedures with the accounting firm, reducing monthly closing time by 1 day
• Acquisition and Integration of a portfolio of mature products Flagyl, Clomid, Danatrol
UPSA
FP&A Manager
PHARMACEUTICALS INDUSTRY
August 2023 - November 2023 (3 months)
Paris, France
Develop the 2024 budget and the 3-year plan for the Belgian and Swiss subsidiaries
Present budget elements to the Executive Committee
Sanofi
Financial Manager Public Health Sub-Saharan Africa
PHARMACEUTICALS INDUSTRY
April 2017 - July 2023 (6 years and 3 months)
Paris, France
• Responsible for the financial performance of a scope of 39 countries in Sub-Saharan Africa for public health medicines. Products are distributed and promoted by two exclusive distributors (2022 turnover: €62M / +16% in 21; +2% in 22)
• Draft, Negotiate, and Manage new distribution and promotion contracts